Literature DB >> 21305352

Transition of young adults with phenylketonuria from pediatric to adult care.

Ulrike Mütze1, Annika Roth, Johannes F W Weigel, Skadi Beblo, Christoph G Baerwald, Peter Bührdel, Wieland Kiess.   

Abstract

BACKGROUND: Transition from pediatric to adult health care is a particularly vulnerable period for patients with inborn metabolic diseases. Aim of the present study was to evaluate the current transition situation of patients with phenylketonuria (PKU) in Leipzig, Germany, by analysis of the medical care, metabolic control, patients' satisfaction, socio-economic and psychosocial status, in order to identify areas of weakness and potential improvement.
METHODS: Patients who had been transferred from pediatric to adult medical care between 2005 and 2008 were identified. An interview was performed using a questionnaire. Pediatric case notes and the present physician's case notes were analyzed retrospectively. Socio-demographic data were compared to data derived from the annual statistics of the city of Leipzig, Germany in 2008.
RESULTS: seventy two transferred patients were identified and included in the study, 48 patients responded to the questionnaire, the data of 24 non-responders were analysed retrospectively. About 90% of the responding patients with PKU were satisfied with the current transition situation. However, they agreed to several suggestions of improvement. Most specifically an interdisciplinary appointment before the definite transfer to the adult clinics was asked for. At the time of transition, most of the patients were in good metabolic control according to current treatment guidelines (median dried blood phenylalanine concentration 853 μmol/l before versus 690 μmol/l after transition). Of the interviewed patients 92% were still on a low phenylalanine diet in combination with the intake of a phenylalanine free amino acid mixture. Of the interviewees 77% carried a secondary school certificate or a secondary modern school qualification, but only 19% had achieved senior high school diploma (controls 38.2%). Marital status was comparable with the population of Leipzig. However, fewer patients with PKU had children (15% versus 37%).
CONCLUSION: Transition of patients with PKU from pediatric to adult care seems to be successful in Leipzig. Patients were mostly satisfied with the transition situation. Still, some suggestions for improvements appeared to be desirable. During transition medical care and metabolic control were stable. However, with regard to psychosocial and socioeconomic data differences to the control population were detected.

Entities:  

Mesh:

Year:  2011        PMID: 21305352     DOI: 10.1007/s10545-011-9284-x

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  41 in total

Review 1.  Transition from paediatric to adult care. Bridging the gaps or passing the buck?

Authors:  R Viner
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 2.  The adolescent with a chronic condition. Part II: healthcare provision.

Authors:  P-A Michaud; J-C Suris; R Viner
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

3.  Evaluation of patients' opinion and metabolic control after transfer of young adults with type 1 diabetes from a pediatric diabetes clinic to adult care.

Authors:  F P Busse; P Hiermann; A Galler; M Stumvoll; T Wiessner; W Kiess; T M Kapellen
Journal:  Horm Res       Date:  2006-10-25

4.  Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine.

Authors:  R W Blum; D Garell; C H Hodgman; T W Jorissen; N A Okinow; D P Orr; G B Slap
Journal:  J Adolesc Health       Date:  1993-11       Impact factor: 5.012

5.  Behaviour and school achievement in patients with early and continuously treated phenylketonuria.

Authors:  B A Stemerdink; A F Kalverboer; J J van der Meere; M W van der Molen; J Huisman; L W de Jong; F M Slijper; P H Verkerk; F J van Spronsen
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

Review 6.  Outcomes beyond phenylalanine: an international perspective.

Authors:  Francois Feillet; Anita MacDonald; Danielle Hartung Perron; Barbara Burton
Journal:  Mol Genet Metab       Date:  2010       Impact factor: 4.797

7.  Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria.

Authors:  P Burgard; M Armbruster; E Schmidt; A Rupp
Journal:  Acta Paediatr Suppl       Date:  1994-12

8.  A case of maternal PKU syndrome despite intensive patient counseling.

Authors:  Susette Unger; Johannes F W Weigel; Holger Stepan; Christoph G O Baerwald
Journal:  Wien Med Wochenschr       Date:  2009-10

Review 9.  Adult issues in phenylketonuria.

Authors:  M P A Hoeks; M den Heijer; M C H Janssen
Journal:  Neth J Med       Date:  2009-01       Impact factor: 1.422

10.  Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU).

Authors:  Eva Simon; Martin Schwarz; Judith Roos; Nico Dragano; Max Geraedts; Johannes Siegrist; Gudrun Kamp; Udo Wendel
Journal:  Health Qual Life Outcomes       Date:  2008-03-26       Impact factor: 3.186

View more
  24 in total

1.  Nutritional Changes and Micronutrient Supply in Patients with Phenylketonuria Under Therapy with Tetrahydrobiopterin (BH(4)).

Authors:  A G Thiele; J F Weigel; B Ziesch; C Rohde; U Mütze; U Ceglarek; J Thiery; A S Müller; W Kiess; S Beblo
Journal:  JIMD Rep       Date:  2012-10-17

2.  Practical aspects of recruitment and retention in clinical trials of rare genetic diseases: the phenylketonuria (PKU) experience.

Authors:  Stephanie J DeWard; Ashley Wilson; Heather Bausell; Ashley S Volz; Kimberly Mooney
Journal:  J Genet Couns       Date:  2013-09-08       Impact factor: 2.537

3.  Clinical therapeutics for phenylketonuria.

Authors:  Jaspreet Singh Kochhar; Sui Yung Chan; Pei Shi Ong; Lifeng Kang
Journal:  Drug Deliv Transl Res       Date:  2012-08       Impact factor: 4.617

4.  Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life.

Authors:  B Ziesch; J Weigel; A Thiele; U Mütze; C Rohde; U Ceglarek; J Thiery; W Kiess; S Beblo
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

5.  Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents.

Authors:  Eva Thimm; Lisa Elena Schmidt; Katrin Heldt; Ute Spiekerkoetter
Journal:  J Inherit Metab Dis       Date:  2013-01-08       Impact factor: 4.982

6.  Metabolic Clinic Atlas: Organization of Care for Children with Inherited Metabolic Disease in Canada.

Authors:  Monica F Lamoureux; Kylie Tingley; Jonathan B Kronick; Beth K Potter; Alicia K J Chan; Doug Coyle; Linda Dodds; Sarah Dyack; Annette Feigenbaum; Michael Geraghty; Jane Gillis; Cheryl Rockman-Greenberg; Aneal Khan; Julian Little; Jennifer MacKenzie; Bruno Maranda; Aizeddin Mhanni; John J Mitchell; Grant Mitchell; Anne-Marie Laberge; Murray Potter; Chitra Prasad; Komudi Siriwardena; Kathy N Speechley; Sylvia Stockler; Yannis Trakadis; Lesley Turner; Clara Van Karnebeek; Kumanan Wilson; Pranesh Chakraborty
Journal:  JIMD Rep       Date:  2015-02-26

7.  Management of adult patients with phenylketonuria: survey results from 24 countries.

Authors:  Friedrich K Trefz; Francjan J van Spronsen; Anita MacDonald; François Feillet; Ania C Muntau; Amaya Belanger-Quintana; Alberto Burlina; Mübeccel Demirkol; Marcello Giovannini; Christoph Gasteyger
Journal:  Eur J Pediatr       Date:  2014-12-06       Impact factor: 3.183

8.  Relationships Between Childhood Experiences and Adulthood Outcomes in Women with PKU: A Qualitative Analysis.

Authors:  Rachel M Roberts; Tamara Muller; Annabel Sweeney; Drago Bratkovic; Anne Gannoni; Brianna Morante
Journal:  JIMD Rep       Date:  2016-06-14

Review 9.  Organic acidurias in adults: late complications and management.

Authors:  Ali Tunç Tuncel; Nikolas Boy; Marina A Morath; Friederike Hörster; Ulrike Mütze; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2018-01-15       Impact factor: 4.982

Review 10.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.